Syrogiannopoulos G A, Lourida A N, Theodoridou M C, Pappas I G, Babilis G C, Economidis J J, Zoumboulakis D J, Beratis N G, Matsaniotis N S
Department of Pediatrics, University of Patras, Medical School, Greece.
J Infect Dis. 1994 Apr;169(4):853-8. doi: 10.1093/infdis/169.4.853.
Four-day dexamethasone therapy has been used to treat bacterial meningitis. This prospective, randomized study compared the effect of a 2-day versus a 4-day regimen. Children (n = 118, ages 2.5 months to 15 years) were evaluated; 50% of the cases were due to Neisseria meningitidis and 40% to Haemophilus influenzae type b. Patients were treated intravenously (iv) mainly with conventional antimicrobial therapy and were randomly assigned to receive dexamethasone, 0.15 mg/kg iv every 6 h for 2 or 4 days. The clinical response was similar for both dexamethasone regimens. The meningococcal meningitis patients survived without neurologic or audiologic sequelae. On long-term follow-up, neurologic sequelae or moderate or more severe unilateral or bilateral hearing impairment (or both) were found in 1.8% and 3.8% of patients treated with dexamethasone for 2 and 4 days, respectively. The 2-day regimen appears appropriate for the treatment of H. influenzae and meningococcal meningitis.
四天的地塞米松疗法已被用于治疗细菌性脑膜炎。这项前瞻性随机研究比较了两天疗程与四天疗程的效果。对儿童(n = 118,年龄2.5个月至15岁)进行了评估;50%的病例由脑膜炎奈瑟菌引起,40%由b型流感嗜血杆菌引起。患者主要接受静脉注射(iv)常规抗菌治疗,并被随机分配接受地塞米松治疗,静脉注射剂量为0.15 mg/kg,每6小时一次,持续2天或4天。两种地塞米松疗程的临床反应相似。脑膜炎球菌性脑膜炎患者存活,无神经或听力后遗症。在长期随访中,接受地塞米松治疗2天和4天的患者中,分别有1.8%和3.8%出现神经后遗症或中度或更严重的单侧或双侧听力障碍(或两者兼有)。两天疗程似乎适用于治疗b型流感嗜血杆菌和脑膜炎球菌性脑膜炎。